gabapentin has been researched along with Herpes Zoster in 66 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Herpes Zoster: An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To estimate the cost-effectiveness of branded pregabalin (PGB) versus generic gabapentin (GBP) in patients with neuropathic pain (NeP) due to painful diabetic polyneuropathy (DPN) or post-herpetic neuralgia (PHN) in Spain." | 9.12 | Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia. ( Díaz, S; Dukes, E; Rejas, J; Rodríguez, MJ; Vera-Llonch, M, 2007) |
| "Gabapentin has been shown to provide pain relief for post-herpetic neuralgia at dosage of 1200 to 2400 mg/day." | 9.11 | Starting dose of gabapentin for patients with post-herpetic neuralgia--a dose-response study. ( Jean, WH; Mok, MS; Sun, WZ; Wu, CC, 2005) |
| "This randomized, double-blind, placebo-controlled crossover study measured the effect of a single dose of oral gabapentin (900 mg) on pain and allodynia associated with herpes zoster." | 9.11 | A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster. ( Berry, JD; Petersen, KL, 2005) |
| "A multicentre double blind, randomised, placebo controlled 7-week study evaluated the efficacy and safety of gabapentin 1800 or 2400 mg/day in treating postherpetic neuralgia." | 9.09 | Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. ( Maton, S; Rice, ASC, 2001) |
| "Gabapentin offers an effective, safe alternative therapy or co-therapy for the listed painful conditions and tremor; it does not affect the metabolism of other medications and is well tolerated." | 9.08 | Gabapentin for treatment of pain and tremor: a large case series. ( Merren, MD, 1998) |
| "Gabapentin is a structural analogue of the neurotransmitter gamma-aminobutyric acid (GABA) approved for use in adults with postherpetic neuralgia." | 8.82 | Gabapentin: in postherpetic neuralgia. ( Curran, MP; Wagstaff, AJ, 2003) |
| "Gabapentin is a very promising medication in the treatment of post-herpetic neuralgia and pain." | 8.82 | The role of gabapentin in treating diseases with cutaneous manifestations and pain. ( Scheinfeld, N, 2003) |
| " Search terms used were postherpetic neuralgia; zoster; gabapentin; neuropathic pain; pain; pharmacoeconomic; cost; controlled clinical trial; randomized, controlled trial; postherpetic neuralgia and gabapentin; gabapentin and pain; treatment and postherpetic neuralgia; gabapentin and age; gabapentin and gender; gabapentin and ethnicity; and gabapentin and pharmacokinetics." | 8.82 | The use of gabapentin for the treatment of postherpetic neuralgia. ( Kennedy, DH; Singh, D, 2003) |
| "The literature search identified 2 published studies of the efficacy of gabapentin in a total of 563 patients with PHN that had persisted for at least 3 months after the healing of herpes zoster rash." | 8.82 | Use of gabapentin for postherpetic neuralgia: results of two randomized, placebo-controlled studies. ( Glanzman, RL; Stacey, BR, 2003) |
| "Gabapentin has been shown to be well tolerated and effective in the management of the pain associated with postherpetic neuralgia (PHN)." | 8.82 | Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia. ( Huang, S; Parsons, B; Tive, L, 2004) |
| "Gabapentin, which has been approved for add-on therapy of focal seizures, is increasingly used for treatment of neuropathic pain." | 8.81 | [Gabapentin therapy for pain]. ( Block, F, 2001) |
| "The frequency of PHN after untreated zoster varies widely." | 7.79 | Postherpetic neuralgia: role of gabapentin and other treatment modalities. ( Beydoun, A, 1999) |
| "To evaluate the efficacy of treatment with gabapentin plus valacyclovir hydrochloride for the prevention of postherpetic neuralgia in patients with acute herpes zoster." | 7.77 | Incidence of postherpetic neuralgia after combination treatment with gabapentin and valacyclovir in patients with acute herpes zoster: open-label study. ( Digiorgio, C; Grady, J; Haitz, K; Lapolla, W; Lu, W; Magel, G; Mendoza, N; Tyring, S, 2011) |
| " In order to avoid drug interactions as well as adverse effects of carbamazepine in myasthenia gravis, gabapentin was chosen for the treatment of neuropathic pain." | 7.72 | Treatment of post-herpetic pain in myasthenia gravis: exacerbation of weakness due to gabapentin. ( Beuche, W; Scheschonka, A, 2003) |
| "Gabapentin was initiated at 300 mg/day and gradually titrated to a maximum of 1800 mg/day." | 6.90 | Efficacy of gabapentin for the prevention of postherpetic neuralgia in patients with acute herpes zoster: A double blind, randomized controlled trial. ( Bulilete, O; Leiva, A; Llobera, J; Roca, A; Rullán, M, 2019) |
| "Gabapentin is an anticonvulsant type of analgesic that could prevent the onset of PHN by its antihypersensitivity action in dorsal horn neurons." | 6.84 | Efficacy of gabapentin for prevention of postherpetic neuralgia: study protocol for a randomized controlled clinical trial. ( Bulilete, O; González-Bals, MJ; Leiva, A; Llobera, J; Lorente, P; Roca, A; Rullán, M; Soler, A, 2017) |
| "A 4-week titration period to a maximum dosage of 3600 mg/d of gabapentin or matching placebo." | 6.69 | Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. ( Bernstein, P; Harden, N; Magnus-Miller, L; Rowbotham, M; Stacey, B, 1998) |
| "Early treatment of herpes zoster neuralgia is of great significance to reduce the incidence of PHN." | 5.72 | Effective treatment of high-voltage pulsed radiofrequency combined with oxygen-ozone injection in acute zoster neuralgia. ( Du, HY; Jia, LL; Li, LM; Yu, WL; Zhang, ZL; Zheng, BS, 2022) |
| " Up to estimated 336 patients (interim analyses) with acute herpes zoster pain (VAS > 30 mm) will be randomised to one of three groups (a) semi-standardised acupuncture (168 patients); (b) gabapentine with individualised dosage between 900-3600 mg/d (84 patients); (c) sham laser acupuncture." | 5.14 | Acupuncture in acute herpes zoster pain therapy (ACUZoster) - design and protocol of a randomised controlled trial. ( Fleckenstein, J; Hoffrogge, P; Irnich, D; Kramer, S; Lang, PM; Lehmeyer, L; Mansmann, U; Pfab, F; Ring, J; Schober, GM; Schotten, KJ; Thoma, S; Weisenseel, P, 2009) |
| "To estimate the cost-effectiveness of branded pregabalin (PGB) versus generic gabapentin (GBP) in patients with neuropathic pain (NeP) due to painful diabetic polyneuropathy (DPN) or post-herpetic neuralgia (PHN) in Spain." | 5.12 | Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia. ( Díaz, S; Dukes, E; Rejas, J; Rodríguez, MJ; Vera-Llonch, M, 2007) |
| "Gabapentin has been shown to provide pain relief for post-herpetic neuralgia at dosage of 1200 to 2400 mg/day." | 5.11 | Starting dose of gabapentin for patients with post-herpetic neuralgia--a dose-response study. ( Jean, WH; Mok, MS; Sun, WZ; Wu, CC, 2005) |
| "This randomized, double-blind, placebo-controlled crossover study measured the effect of a single dose of oral gabapentin (900 mg) on pain and allodynia associated with herpes zoster." | 5.11 | A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster. ( Berry, JD; Petersen, KL, 2005) |
| "A multicentre double blind, randomised, placebo controlled 7-week study evaluated the efficacy and safety of gabapentin 1800 or 2400 mg/day in treating postherpetic neuralgia." | 5.09 | Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. ( Maton, S; Rice, ASC, 2001) |
| "Gabapentin offers an effective, safe alternative therapy or co-therapy for the listed painful conditions and tremor; it does not affect the metabolism of other medications and is well tolerated." | 5.08 | Gabapentin for treatment of pain and tremor: a large case series. ( Merren, MD, 1998) |
| "Gabapentin has been shown to be well tolerated and effective in the management of the pain associated with postherpetic neuralgia (PHN)." | 4.82 | Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia. ( Huang, S; Parsons, B; Tive, L, 2004) |
| "Gabapentin is a structural analogue of the neurotransmitter gamma-aminobutyric acid (GABA) approved for use in adults with postherpetic neuralgia." | 4.82 | Gabapentin: in postherpetic neuralgia. ( Curran, MP; Wagstaff, AJ, 2003) |
| "The literature search identified 2 published studies of the efficacy of gabapentin in a total of 563 patients with PHN that had persisted for at least 3 months after the healing of herpes zoster rash." | 4.82 | Use of gabapentin for postherpetic neuralgia: results of two randomized, placebo-controlled studies. ( Glanzman, RL; Stacey, BR, 2003) |
| " Search terms used were postherpetic neuralgia; zoster; gabapentin; neuropathic pain; pain; pharmacoeconomic; cost; controlled clinical trial; randomized, controlled trial; postherpetic neuralgia and gabapentin; gabapentin and pain; treatment and postherpetic neuralgia; gabapentin and age; gabapentin and gender; gabapentin and ethnicity; and gabapentin and pharmacokinetics." | 4.82 | The use of gabapentin for the treatment of postherpetic neuralgia. ( Kennedy, DH; Singh, D, 2003) |
| "Gabapentin is a very promising medication in the treatment of post-herpetic neuralgia and pain." | 4.82 | The role of gabapentin in treating diseases with cutaneous manifestations and pain. ( Scheinfeld, N, 2003) |
| "Gabapentin, which has been approved for add-on therapy of focal seizures, is increasingly used for treatment of neuropathic pain." | 4.81 | [Gabapentin therapy for pain]. ( Block, F, 2001) |
| " She was diagnosed with shingles, started on valacyclovir and gabapentin, and eventually went on to deliver a healthy infant." | 3.88 | Shingles in Pregnancy: An Elusive Case of Left Upper Quadrant Abdominal Pain. ( Chin, JM; Schlueter, RJ; Wong, JW, 2018) |
| "The frequency of PHN after untreated zoster varies widely." | 3.79 | Postherpetic neuralgia: role of gabapentin and other treatment modalities. ( Beydoun, A, 1999) |
| " Gabapentin has been successfully used to treat cutaneous pain and pruritus in a variety of conditions." | 3.77 | A case of post-herpetic itch resolved with gabapentin. ( Jagdeo, J; Kroshinsky, D, 2011) |
| "To evaluate the efficacy of treatment with gabapentin plus valacyclovir hydrochloride for the prevention of postherpetic neuralgia in patients with acute herpes zoster." | 3.77 | Incidence of postherpetic neuralgia after combination treatment with gabapentin and valacyclovir in patients with acute herpes zoster: open-label study. ( Digiorgio, C; Grady, J; Haitz, K; Lapolla, W; Lu, W; Magel, G; Mendoza, N; Tyring, S, 2011) |
| " In order to avoid drug interactions as well as adverse effects of carbamazepine in myasthenia gravis, gabapentin was chosen for the treatment of neuropathic pain." | 3.72 | Treatment of post-herpetic pain in myasthenia gravis: exacerbation of weakness due to gabapentin. ( Beuche, W; Scheschonka, A, 2003) |
| "Gabapentin was initiated at 300 mg/day and gradually titrated to a maximum of 1800 mg/day." | 2.90 | Efficacy of gabapentin for the prevention of postherpetic neuralgia in patients with acute herpes zoster: A double blind, randomized controlled trial. ( Bulilete, O; Leiva, A; Llobera, J; Roca, A; Rullán, M, 2019) |
| "Gabapentin is an anticonvulsant type of analgesic that could prevent the onset of PHN by its antihypersensitivity action in dorsal horn neurons." | 2.84 | Efficacy of gabapentin for prevention of postherpetic neuralgia: study protocol for a randomized controlled clinical trial. ( Bulilete, O; González-Bals, MJ; Leiva, A; Llobera, J; Lorente, P; Roca, A; Rullán, M; Soler, A, 2017) |
| "Pain was assessed using a visual analog scale (VAS)." | 2.71 | Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin. ( Auletta, C; Brogi, A; Brogi, F; Criscuolo, S; Lippi, S, 2005) |
| "A 4-week titration period to a maximum dosage of 3600 mg/d of gabapentin or matching placebo." | 2.69 | Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. ( Bernstein, P; Harden, N; Magnus-Miller, L; Rowbotham, M; Stacey, B, 1998) |
| "Once established, postherpetic neuralgia is particularly difficult to treat, and is often resistant to conventional analgesics." | 2.47 | [Development of animal models of herpetic pain and postherpetic neuralgia and elucidation of the mechanisms of the onset and inhibition of allodynia]. ( Takasaki, I, 2011) |
| "Trigeminal neuralgia is a unique neuropathic pain disorder with a specific therapy." | 2.42 | Management issues of neuropathic trigeminal pain from a medical perspective. ( Watson, CP, 2004) |
| "Diagnosis and management of neuropathic pain syndromes is challenging." | 2.42 | Diagnosis and management of neuropathic pain: a balanced approach to treatment. ( Nicholson, BD, 2003) |
| "The most common risk factor for shingles and its potential sequela, PHN, is advanced age." | 2.42 | Post-herpetic neuralgia case study: optimizing pain control. ( Baron, R, 2004) |
| "Early treatment of herpes zoster neuralgia is of great significance to reduce the incidence of PHN." | 1.72 | Effective treatment of high-voltage pulsed radiofrequency combined with oxygen-ozone injection in acute zoster neuralgia. ( Du, HY; Jia, LL; Li, LM; Yu, WL; Zhang, ZL; Zheng, BS, 2022) |
| " Nine adverse drug reactions, mostly mild, nonserious, and nonpreventable, were reported." | 1.48 | An Evaluation of Efficacy and Safety of Commonly Prescribed Drugs and Effect of These Drugs on Quality of Sleep in Patients Suffering From Zoster-Associated Pain. ( Desai, CK; Desai, MK; Kapadia, JD; Nayak, MK; Shah, BJ, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (10.61) | 18.2507 |
| 2000's | 36 (54.55) | 29.6817 |
| 2010's | 17 (25.76) | 24.3611 |
| 2020's | 6 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, E | 1 |
| Fei, Y | 1 |
| Xu, L | 1 |
| Huang, B | 1 |
| Yao, M | 1 |
| Li, J | 1 |
| Huang, Y | 1 |
| Lin, J | 1 |
| Li, LM | 1 |
| Zhang, ZL | 1 |
| Zheng, BS | 1 |
| Jia, LL | 1 |
| Yu, WL | 1 |
| Du, HY | 1 |
| Menaldi, SL | 1 |
| Halim, PA | 1 |
| Kurniawan, K | 1 |
| Changa, AR | 1 |
| Jain, R | 1 |
| Tan, SM | 1 |
| Sek, KS | 1 |
| Teng, GG | 1 |
| Nayak, MK | 1 |
| Kapadia, JD | 1 |
| Desai, CK | 1 |
| Desai, MK | 1 |
| Shah, BJ | 1 |
| Wong, JW | 1 |
| Chin, JM | 1 |
| Schlueter, RJ | 1 |
| Ghanavatian, S | 1 |
| Wie, CS | 1 |
| Low, RS | 1 |
| Zhang, N | 1 |
| Montoya, JM | 1 |
| Dhaliwal, GS | 1 |
| Swanson, DL | 1 |
| Hochman, E | 1 |
| Ferenczi, K | 1 |
| Payette, MJ | 1 |
| Bulilete, O | 2 |
| Leiva, A | 2 |
| Rullán, M | 2 |
| Roca, A | 2 |
| Llobera, J | 2 |
| Johnson, RW | 2 |
| Rice, AS | 1 |
| Lee, EG | 1 |
| Lee, HJ | 1 |
| Hyun, DJ | 1 |
| Min, K | 1 |
| Kim, DH | 1 |
| Yoon, MS | 1 |
| Soler, A | 1 |
| González-Bals, MJ | 1 |
| Lorente, P | 1 |
| Dworkin, RH | 3 |
| Barbano, RL | 1 |
| Tyring, SK | 2 |
| Betts, RF | 1 |
| McDermott, MP | 1 |
| Pennella-Vaughan, J | 1 |
| Bennett, GJ | 1 |
| Berber, E | 1 |
| Gnann, JW | 1 |
| Irvine, C | 1 |
| Kamp, C | 1 |
| Kieburtz, K | 1 |
| Max, MB | 1 |
| Schmader, KE | 2 |
| Fleckenstein, J | 1 |
| Kramer, S | 1 |
| Hoffrogge, P | 1 |
| Thoma, S | 1 |
| Lang, PM | 1 |
| Lehmeyer, L | 1 |
| Schober, GM | 1 |
| Pfab, F | 1 |
| Ring, J | 1 |
| Weisenseel, P | 1 |
| Schotten, KJ | 1 |
| Mansmann, U | 1 |
| Irnich, D | 1 |
| Sheen, VL | 1 |
| Ohaegbulam, C | 1 |
| Rencus, T | 1 |
| Tandon, D | 1 |
| Ong, OL | 1 |
| Churchyard, AC | 1 |
| New, PW | 1 |
| Jagdeo, J | 1 |
| Kroshinsky, D | 1 |
| Micucci, CJ | 1 |
| Nease, EK | 1 |
| Tuten, HR | 1 |
| Takasaki, I | 1 |
| Lapolla, W | 1 |
| Digiorgio, C | 1 |
| Haitz, K | 1 |
| Magel, G | 1 |
| Mendoza, N | 1 |
| Grady, J | 1 |
| Lu, W | 1 |
| Tyring, S | 1 |
| Green, CB | 1 |
| Stratman, EJ | 1 |
| Chen, WH | 1 |
| Li, TH | 1 |
| Lee, LH | 1 |
| Huang, CC | 1 |
| Thakur, R | 1 |
| Philip, AG | 1 |
| Scheinfeld, N | 1 |
| Singh, D | 1 |
| Kennedy, DH | 1 |
| Scheschonka, A | 1 |
| Beuche, W | 1 |
| Curran, MP | 1 |
| Wagstaff, AJ | 1 |
| Stacey, BR | 2 |
| Junker, U | 1 |
| Brunnmüller, U | 1 |
| Glanzman, RL | 1 |
| Berger, A | 1 |
| Dukes, E | 2 |
| McCarberg, B | 1 |
| Liss, M | 1 |
| Oster, G | 1 |
| Nicholson, BD | 1 |
| Baron, R | 1 |
| Lim, LS | 1 |
| Takahashi, PY | 1 |
| Dubinsky, RM | 1 |
| Kabbani, H | 1 |
| El-Chami, Z | 1 |
| Boutwell, C | 1 |
| Ali, H | 1 |
| Sra, KK | 1 |
| Wareham, D | 2 |
| Parsons, B | 1 |
| Tive, L | 1 |
| Huang, S | 1 |
| Douglas, MW | 1 |
| Cunningham, AL | 1 |
| Criscuolo, S | 2 |
| Auletta, C | 2 |
| Lippi, S | 2 |
| Brogi, F | 2 |
| Brogi, A | 2 |
| Watson, CP | 1 |
| Jean, WH | 1 |
| Wu, CC | 1 |
| Mok, MS | 1 |
| Sun, WZ | 1 |
| Tenser, RB | 1 |
| Berry, JD | 1 |
| Petersen, KL | 1 |
| Garry, EM | 1 |
| Delaney, A | 1 |
| Anderson, HA | 1 |
| Sirinathsinghji, EC | 1 |
| Clapp, RH | 1 |
| Martin, WJ | 1 |
| Kinchington, PR | 1 |
| Krah, DL | 1 |
| Abbadie, C | 1 |
| Fleetwood-Walker, SM | 1 |
| Moulin, D | 1 |
| Rodríguez, MJ | 1 |
| Díaz, S | 1 |
| Vera-Llonch, M | 1 |
| Rejas, J | 1 |
| Niscola, P | 1 |
| Perrotti, AP | 1 |
| del Poeta, G | 1 |
| Romani, C | 1 |
| Palombi, M | 1 |
| Piccioni, D | 1 |
| Scaramucci, L | 1 |
| Tolu, B | 1 |
| Tendas, A | 1 |
| Cupelli, L | 1 |
| Abruzzese, E | 1 |
| D'Elia, GM | 1 |
| Brunetti, GA | 1 |
| Maurillo, L | 1 |
| Giovannini, M | 1 |
| Cartoni, C | 1 |
| de Fabritiis, P | 1 |
| Laville, MA | 1 |
| de la Gastine, B | 1 |
| Husson, B | 1 |
| Le Boisselier, R | 1 |
| Mosquet, B | 1 |
| Coquerel, A | 1 |
| Segal, AZ | 1 |
| Rordorf, G | 1 |
| Merren, MD | 1 |
| Rowbotham, M | 1 |
| Harden, N | 1 |
| Stacey, B | 1 |
| Bernstein, P | 1 |
| Magnus-Miller, L | 1 |
| Low, PA | 1 |
| Dotson, RM | 1 |
| Colman, E | 1 |
| Stadel, BV | 1 |
| Marples, IL | 1 |
| Murray, P | 1 |
| Beydoun, A | 1 |
| Carver, A | 1 |
| Payne, R | 1 |
| Foley, K | 1 |
| Block, F | 1 |
| Rice, ASC | 1 |
| Maton, S | 1 |
| Bowsher, D | 1 |
| Gehling, M | 1 |
| Tryba, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prophylactic Duloxetine Administration During Acute Herpes Zoster Prevents Postherpetic Neuralgia[NCT04313335] | 750 participants (Anticipated) | Interventional | 2021-03-01 | Recruiting | |||
| Efficacy of Electroacupuncture Therapy in Patients With Postherpetic Neuralgia: a Multicentre Randomised Controlled Trial[NCT04594226] | 132 participants (Actual) | Interventional | 2020-11-11 | Completed | |||
| Effect of Early Use of Oxycodone During the Acute Phase of Herpes Zoster on Preventing Postherpetic Neuralgia[NCT03120962] | 140 participants (Anticipated) | Interventional | 2017-05-31 | Not yet recruiting | |||
| Analgetic Effectiveness of Acupuncture When Compared to a Standardised Analgesic Regimen in the Treatment of Herpes Zoster Neuralgia[NCT00885586] | Phase 4 | 68 participants (Actual) | Interventional | 2008-11-30 | Completed | ||
| The Efficacy and Safety of Intradermal Acupuncture for Acute Herpes Zoster: Study Protocol for a Randomized Controlled Trial[NCT05348382] | 72 participants (Anticipated) | Interventional | 2022-07-04 | Recruiting | |||
| [NCT01250561] | 133 participants (Actual) | Interventional | 2002-02-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
21 reviews available for gabapentin and Herpes Zoster
| Article | Year |
|---|---|
Efficacy of gabapentinoids for acute herpes zoster in preventing postherpetic neuralgia: a systematic review of randomized controlled trials.
Topics: Analgesics; Gabapentin; Herpes Zoster; Humans; Neuralgia, Postherpetic; Randomized Controlled Trials | 2022 |
Clinical practice. Postherpetic neuralgia.
Topics: Administration, Topical; Aged; Amines; Analgesics, Opioid; Anesthetics, Local; Antipyretics; Capsaic | 2014 |
Clinical practice. Postherpetic neuralgia.
Topics: Administration, Topical; Aged; Amines; Analgesics, Opioid; Anesthetics, Local; Antipyretics; Capsaic | 2014 |
Clinical practice. Postherpetic neuralgia.
Topics: Administration, Topical; Aged; Amines; Analgesics, Opioid; Anesthetics, Local; Antipyretics; Capsaic | 2014 |
Clinical practice. Postherpetic neuralgia.
Topics: Administration, Topical; Aged; Amines; Analgesics, Opioid; Anesthetics, Local; Antipyretics; Capsaic | 2014 |
[Development of animal models of herpetic pain and postherpetic neuralgia and elucidation of the mechanisms of the onset and inhibition of allodynia].
Topics: Amines; Analgesics; Animals; Anticonvulsants; Cyclohexanecarboxylic Acids; Cyclooxygenase Inhibitors | 2011 |
Chronic pain perspectives: Treating herpes zoster and postherpetic neuralgia: an evidence-based approach.
Topics: Amines; Analgesics; Analgesics, Opioid; Antidepressive Agents, Tricyclic; Antipruritics; Capsaicin; | 2012 |
Treatment and prevention of postherpetic neuralgia.
Topics: Acetates; Amines; Analgesics; Analgesics, Opioid; Cyclohexanecarboxylic Acids; Drug Therapy, Combina | 2003 |
The role of gabapentin in treating diseases with cutaneous manifestations and pain.
Topics: Acetates; Amines; Analgesics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Herp | 2003 |
The use of gabapentin for the treatment of postherpetic neuralgia.
Topics: Acetates; Amines; Analgesics; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Drug Interactio | 2003 |
Gabapentin: in postherpetic neuralgia.
Topics: Acetates; Amines; Animals; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Herpes | 2003 |
Gabapentin: a viewpoint by Brett R. Stacey.
Topics: Acetates; Amines; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Herpes Zoster; H | 2003 |
Use of gabapentin for postherpetic neuralgia: results of two randomized, placebo-controlled studies.
Topics: Acetates; Amines; Analgesics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Herp | 2003 |
Diagnosis and management of neuropathic pain: a balanced approach to treatment.
Topics: Acetates; Amines; Antidepressive Agents; Chronic Disease; Cyclohexanecarboxylic Acids; Gabapentin; g | 2003 |
Post-herpetic neuralgia case study: optimizing pain control.
Topics: Acetates; Aged; Amines; Amitriptyline; Analgesics; Antidepressive Agents, Tricyclic; Cyclohexanecarb | 2004 |
80-year-old man with fever and ear pain.
Topics: Acetates; Acyclovir; Age Factors; Aged; Aged, 80 and over; Amines; Analgesics; Antiviral Agents; Cyc | 2004 |
Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology.
Topics: Acupuncture Analgesia; Administration, Cutaneous; Amines; Analgesics; Analgesics, Opioid; Anti-Infla | 2004 |
Postherpetic neuralgia.
Topics: 2-Aminopurine; Acyclovir; Adrenal Cortex Hormones; Adult; Amines; Amitriptyline; Analgesics, Non-Nar | 2003 |
Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia.
Topics: Aged; Amines; Analgesics; Cyclohexanecarboxylic Acids; Dizziness; Dose-Response Relationship, Drug; | 2004 |
Tolerability of treatments for postherpetic neuralgia.
Topics: Amines; Anticonvulsants; Antidepressive Agents, Tricyclic; Cyclohexanecarboxylic Acids; Gabapentin; | 2004 |
Management issues of neuropathic trigeminal pain from a medical perspective.
Topics: Amines; Analgesics, Non-Narcotic; Anticonvulsants; Antidepressive Agents; Baclofen; Carbamazepine; C | 2004 |
Postherpetic neuralgia.
Topics: 2-Aminopurine; Acyclovir; Amines; Antidepressive Agents, Tricyclic; Antiviral Agents; Arabinofuranos | 2004 |
Postherpetic neuralgia: role of gabapentin and other treatment modalities.
Topics: Acetates; Administration, Topical; Age Factors; Aged; Ambulatory Care; Amines; Analgesics; Anticonvu | 1999 |
[Gabapentin therapy for pain].
Topics: Acetates; Amines; Analgesics; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Diabetic Neurop | 2001 |
13 trials available for gabapentin and Herpes Zoster
| Article | Year |
|---|---|
Efficacy of gabapentin for the prevention of postherpetic neuralgia in patients with acute herpes zoster: A double blind, randomized controlled trial.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Gabapentin; Herpes Zoster; Humans; Male; Middl | 2019 |
Efficacy of low dose gabapentin in acute herpes zoster for preventing postherpetic neuralgia: a prospective controlled study.
Topics: Acetaminophen; Acyclovir; Aged; Aged, 80 and over; Amines; Analgesics; Analgesics, Non-Narcotic; Ant | 2016 |
Efficacy of gabapentin for prevention of postherpetic neuralgia: study protocol for a randomized controlled clinical trial.
Topics: Acyclovir; Amines; Analgesics; Antiviral Agents; Clinical Protocols; Cyclohexanecarboxylic Acids; Do | 2017 |
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster.
Topics: Acute Disease; Aged; Amines; Analgesics, Opioid; Clinical Trials as Topic; Cyclohexanecarboxylic Aci | 2009 |
Acupuncture in acute herpes zoster pain therapy (ACUZoster) - design and protocol of a randomised controlled trial.
Topics: Acupuncture Therapy; Acute Disease; Adult; Amines; Analgesics; Anticonvulsants; Cyclohexanecarboxyli | 2009 |
Acupuncture in acute herpes zoster pain therapy (ACUZoster) - design and protocol of a randomised controlled trial.
Topics: Acupuncture Therapy; Acute Disease; Adult; Amines; Analgesics; Anticonvulsants; Cyclohexanecarboxyli | 2009 |
Acupuncture in acute herpes zoster pain therapy (ACUZoster) - design and protocol of a randomised controlled trial.
Topics: Acupuncture Therapy; Acute Disease; Adult; Amines; Analgesics; Anticonvulsants; Cyclohexanecarboxyli | 2009 |
Acupuncture in acute herpes zoster pain therapy (ACUZoster) - design and protocol of a randomised controlled trial.
Topics: Acupuncture Therapy; Acute Disease; Adult; Amines; Analgesics; Anticonvulsants; Cyclohexanecarboxyli | 2009 |
Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin.
Topics: Adult; Aged; Aged, 80 and over; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; | 2005 |
Starting dose of gabapentin for patients with post-herpetic neuralgia--a dose-response study.
Topics: Adult; Aged; Aged, 80 and over; Amines; Analgesics; Cyclohexanecarboxylic Acids; Dose-Response Relat | 2005 |
A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amines; Analgesics; Anticonvulsants; Cross-Over Studi | 2005 |
Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia.
Topics: Amines; Cost-Benefit Analysis; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Double-Blind Meth | 2007 |
Gabapentin for treatment of pain and tremor: a large case series.
Topics: Acetates; Adult; Aged; Amines; Analgesics; Anticonvulsants; Arachnoiditis; Cerebellar Neoplasms; Cyc | 1998 |
Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Amines; Analgesics; Anticonvulsants; Cyclohexanecarboxylic | 1998 |
Postherpetic neuralgia: role of gabapentin and other treatment modalities.
Topics: Acetates; Administration, Topical; Age Factors; Aged; Ambulatory Care; Amines; Analgesics; Anticonvu | 1999 |
Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Amines; Analgesics; Cyclohexanecarboxylic Acids; Double-Bl | 2001 |
33 other studies available for gabapentin and Herpes Zoster
| Article | Year |
|---|---|
Effect of Repeated High-voltage Long-duration Pulsed Radiofrequency on Herpetic Neuralgia.
Topics: Gabapentin; Galectin 3; Herpes Zoster; Humans; Interleukin-6; Morphine Derivatives; Neuralgia; Neura | 2022 |
[Efficacy analysis of lidocaine plaster combined with gabapentin in the treatment of herpes zoster neuralgia].
Topics: Aged; Female; Gabapentin; Herpes Zoster; Humans; Lidocaine; Male; Middle Aged; Neuralgia; Quality of | 2022 |
Effective treatment of high-voltage pulsed radiofrequency combined with oxygen-ozone injection in acute zoster neuralgia.
Topics: Gabapentin; Herpes Zoster; Humans; Neuralgia; Neuralgia, Postherpetic; Oxygen; Ozone; Pulsed Radiofr | 2022 |
Herpes zoster lumbar radiculitis.
Topics: Acyclovir; Analgesics; Antiviral Agents; Gabapentin; Herpes Zoster; Humans; Lumbosacral Region; Male | 2020 |
Herpes Zoster-Associated Abdominal Pseudohernia.
Topics: Aged, 80 and over; Analgesics; Gabapentin; Hernia, Abdominal; Herpes Zoster; Humans; Male | 2021 |
An Evaluation of Efficacy and Safety of Commonly Prescribed Drugs and Effect of These Drugs on Quality of Sleep in Patients Suffering From Zoster-Associated Pain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; | 2018 |
Shingles in Pregnancy: An Elusive Case of Left Upper Quadrant Abdominal Pain.
Topics: Abdominal Pain; Analgesics; Antiviral Agents; Female; Gabapentin; Gynecological Examination; Hawaii; | 2018 |
Premedication With Gabapentin Significantly Reduces the Risk of Postherpetic Neuralgia in Patients With Neuropathy.
Topics: Antiviral Agents; Diabetic Neuropathies; Female; Gabapentin; Herpes Zoster; Humans; Male; Middle Age | 2019 |
A peculiar dermatomal plaque.
Topics: Acetaminophen; Aged; Biopsy; Dermatitis; Drug Combinations; Drug Therapy, Combination; Gabapentin; H | 2019 |
Gabapentin-induced exacerbation of myasthenia gravis.
Topics: Aged; Amines; Cholinesterase Inhibitors; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagoni | 2010 |
The importance of early diagnosis of herpes zoster myelitis.
Topics: Acyclovir; Aged; Amines; Analgesics; Anti-Inflammatory Agents; Antiviral Agents; Cyclohexanecarboxyl | 2010 |
A case of post-herpetic itch resolved with gabapentin.
Topics: Adult; Amines; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Herpes Zost | 2011 |
Hip pain as initial presentation for varicella-zoster infection in an adolescent male.
Topics: Acyclovir; Adolescent; Amines; Analgesics; Antiviral Agents; Cyclohexanecarboxylic Acids; Diagnosis, | 2011 |
Incidence of postherpetic neuralgia after combination treatment with gabapentin and valacyclovir in patients with acute herpes zoster: open-label study.
Topics: Acute Disease; Acyclovir; Aged; Amines; Analgesics; Antiviral Agents; Cyclohexanecarboxylic Acids; D | 2011 |
Prevent rather than treat postherpetic neuralgia by prescribing gabapentin earlier in patients with herpes zoster: comment on "incidence of postherpetic neuralgia after combination treatment with gabapentin and valacyclovir in patients with acute herpes z
Topics: Acyclovir; Amines; Analgesics; Antiviral Agents; Cyclohexanecarboxylic Acids; Female; Gabapentin; ga | 2011 |
Varicella-zoster virus infection and nummular headache: a possible association with epicranial neuralgia.
Topics: 2-Aminopurine; Amines; Analgesics; Antiviral Agents; Comorbidity; Cyclohexanecarboxylic Acids; Famci | 2012 |
Treatment of post-herpetic pain in myasthenia gravis: exacerbation of weakness due to gabapentin.
Topics: Acetates; Amines; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Herpes Z | 2003 |
[Efficacy and tolerability of gabapentin in the treatment of patients with neuropathic pain. Results of an observational study involving 5620 patients].
Topics: Acetates; Amines; Analgesics; Anticonvulsants; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; G | 2003 |
Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgia.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Amines; Analgesics; Analgesics, Opioid; Cycloh | 2003 |
Treatment of postherpetic neuralgia.
Topics: 2-Aminopurine; Acyclovir; Age Factors; Aged; Amines; Analgesics; Analgesics, Opioid; Antidepressive | 2004 |
Oxcarbazepine (Trileptal) monotherapy dramatically improves quality of life in two patients with postherpetic neuralgia refractory to carbamazepine and gabapentin.
Topics: Aged; Amines; Analgesics, Non-Narcotic; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; | 2004 |
Herpes zoster and the prevention of postherpetic neuralgia: beyond antiviral therapy.
Topics: Amines; Analgesics, Opioid; Anticonvulsants; Antiviral Agents; Calcium Channels; Clinical Trials as | 2005 |
Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs.
Topics: Amines; Animals; Anticonvulsants; Behavior, Animal; Cyclohexanecarboxylic Acids; Disease Models, Ani | 2005 |
Does acute pain associated with herpes zoster respond to treatment with gabapentin?
Topics: Acute Disease; Amines; Analgesics; Cross-Over Studies; Cyclohexanecarboxylic Acids; Double-Blind Met | 2006 |
Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measures.
Topics: Acute Disease; Aged; Aged, 80 and over; Amines; Analgesics; Antiviral Agents; Cyclohexanecarboxylic | 2007 |
[Should we care about pregabalin for elderly patients with a history of cardiac dysrhythmia?].
Topics: Aged, 80 and over; Amines; Analgesics; Atrial Fibrillation; Cyclohexanecarboxylic Acids; Female; Gab | 2008 |
Gabapentin as a novel treatment for postherpetic neuralgia.
Topics: Acetates; Aged; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Amin | 1996 |
Symptomatic treatment of painful neuropathy.
Topics: Acetates; Amines; Analgesics; Anticonvulsants; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; G | 1998 |
Gabapentin for postherpetic neuralgia.
Topics: Acetates; Amines; Analgesics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Herp | 1999 |
Neuropathic pain.
Topics: Acetates; Amines; Amitriptyline; Analgesics; Antiviral Agents; Cyclohexanecarboxylic Acids; Drug The | 1999 |
Herpes zoster.
Topics: Acetates; Acute Disease; Amines; Analgesics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobut | 2000 |
Comment on Rice ASC, Maton S, the Postherpetic Neuralgia Study Group (UK), gabapentin in postherpetic neuralgia: a randomized, double blind, placebo-controlled study.
Topics: Acetates; Amines; Analgesics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Herp | 2002 |
Comment on Rice ASC, Maton S, the Postherpetic Neuralgia Study Group (UK), gabapentin in postherpetic neuralgia: a randomized, double blind, placebo-controlled study.
Topics: Acetates; Amines; Analgesics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Herp | 2002 |